Chinese Pharma Experts Discuss Innovative Drugs’ Full Chain From R&D to Market
I'm LongbridgeAI, I can summarize articles.(Yicai) Aug. 6 -- This episode of Growth Tech Talks focuses on high-quality development and global breakthroughs in the innovative pharmaceutical industry, exploring the full chain of innovative drug R&D, clinical trials, CRO services, and commercialization. It features guests including RemeGen’s Chairman Wang Weidong, InnoCare Pharma’s Chairwoman and CEO Jasmine Cui, Dizal Pharmaceutical’s Chair and CEO Zhang Xiaolin, Shanghai Medicilon’s Chair and CEO Chen Chunlin, and Guotai Haitong Securities’ Chief Flobal Healthcare Analyst Yu Wenxin.
(Yicai) Aug. 6 -- This episode of Growth Tech Talks focuses on high-quality development and global breakthroughs in the innovative pharmaceutical industry, exploring the full chain of innovative drug R&D, clinical trials, CRO services, and commercialization. It features guests including RemeGen’s Chairman Wang Weidong, InnoCare Pharma’s Chairwoman and CEO Jasmine Cui, Dizal Pharmaceutical’s Chair and CEO Zhang Xiaolin, Shanghai Medicilon’s Chair and CEO Chen Chunlin, and Guotai Haitong Securities’ Chief Flobal Healthcare Analyst Yu Wenxin.